In the face of stocks that exceed 10 million doses, the new vaccinates collapse, which in just two weeks see a reduction of 41% with only just over 486,000 first doses carried out from 15 to 21 September.
Vaccination hesitation persists in the over 50s and slows vaccination in the 12-19 age group.
This is highlighted by the new monitoring of the Gimbe Foundation.
